<DOC>
	<DOCNO>NCT01573598</DOCNO>
	<brief_summary>Safety Efficacy Vilazodone Major Depressive Disorder</brief_summary>
	<brief_title>Safety Efficacy Vilazodone Major Depressive Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Vilazodone Hydrochloride</mesh_term>
	<criteria>Men woman , 1870 year age Currently meet DSMIVTR criterion Major Depressive Disorder The patient 's current major depressive episode must least 8 week longer 18 month duration Women pregnant , woman breastfeed study , woman childbearing potential practicing reliable method birth control Patients history meeting DSMIVTR criterion : manic , hypomanic mixed episode , include bipolar disorder substanceinduced manic , hypomanic , mixed episode ; depressive episode psychotic catatonic feature ; panic disorder without agoraphobia ; obsessivecompulsive disorder ; Schizophrenia , schizoaffective , psychotic disorder ; bulimia anorexia nervosa ; presence borderline personality disorder antisocial personality disorder ; h. mental retardation , dementia , amnesia , cognitive disorder Patients consider suicide risk</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Major Depressive Disorder</keyword>
	<keyword>Depression</keyword>
</DOC>